Haloinhalation therapy of patients with allergic and vasomotor rhinitis
A N Aleksandrov, A V Chervinskaia, T V Ostrinskaia
PMID: 18833128
Abstract
The results of placebo-controlled randomized trial of effectiveness of haloinhalation treatment with application of individual inhaler Haloneb in 125 patients with allergic and vasomotor rhinitis demonstrated high efficacy of the method. A positive effect was achieved in 90.4% patients with allergic and 92.1% with vasomotor rhinitis. Efficacy of the method is explained by anti-edema, anti-allergic and anti-inflammatory effects of haloinhalation therapy.
